Cov Ntaub Ntawv Qhia Paub Fab Nyiaj Txiag
Tus kws kho mob
medicaid-si-005-multiple-procedure-reduction.pdf
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1311 - 1320 ntawm 4139
Kev Noj Qab Nyob Zoo thiab Kev Noj Qab Haus Huv
2024-preventive-care-recommendations.pdf
Tus kws kho mob
P53-24 MagellanRx Management, a Prime Therapeutics Company (UM) Program: Medical Drug Updates
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2024
Tus kws kho mob
2024 August Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2024
Tus kws kho mob
P51-24 Inpatient Admission, Concurrent Review, and Discharge Submission Process Change for Commercial & Medicare Advantage Members
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2024